Imaging-Based Risk Stratification for Recurrence Risk in Women with a History of Peripartum Cardiomyopathy

Am J Perinatol. 2022 Feb;39(3):225-231. doi: 10.1055/s-0041-1740016. Epub 2021 Dec 2.

Abstract

Objective: Peripartum cardiomyopathy (PPCM) affects 1:1,000 U.S. pregnancies, and while many recover from the disease, the risk of recurrence in subsequent pregnancy (SSP) is high. This study aims to evaluate the utility of left ventricular ejection fraction (LVEF) and global longitudinal strain (GLS) to predict the risk of recurrence of PPCM in SSP.

Study design: We retrospectively evaluated outcomes in women with a history of PPCM and SSP at a large-volume cardioobstetrics program (2008-2019).

Results: There were 18 women who had incident PPCM and pursued SSP. Of 24 pregnancies in these women, 8 (33%) were complicated by the development of recurrent PPCM. LVEF ≥ 52% or GLS ≤ -16 was associated with a low risk of recurrent PPCM.

Conclusion: Approximately one-third of women with PPCM developed recurrent PPCM in SSP. LVEF and GLS on prepregnancy echocardiography may predict the risk of recurrence. Additional studies evaluating risk for recurrence are required to better understand which women are the safest to consider SSP.

Key points: · Peripartum cardiomyopathy affects 1:1000 US pregnancies.. · Approximately one third of women with a history of peripartum cardiomyopathy developed recurrent disease in a subsequent pregnancy.. · A left ventricular ejection fraction ≥52% or global longitudinal strain ≤-16 on echocardiogram is associated with a low risk of recurrence..

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Cardiomyopathies* / diagnostic imaging
  • Cardiomyopathies* / physiopathology
  • Female
  • Humans
  • Peripartum Period
  • Predictive Value of Tests
  • Pregnancy
  • Pregnancy Complications, Cardiovascular / diagnostic imaging
  • Pregnancy Complications, Cardiovascular / physiopathology
  • Prognosis
  • ROC Curve
  • Recurrence
  • Retrospective Studies
  • Risk Assessment / methods*
  • Stroke Volume*
  • Ventricular Dysfunction, Left / physiopathology*